Genotype 4 Chronic Hepatitis C

Genotype 4 Chronic Hepatitis C is the indication for 9 drugs in DrugBank. It is covered by 22 curated, structured indications.

Also known as: Chronic hepatitis C genotype 4 · hepatitis C virus genotype 4
Classified under: Digestive System Diseases
Disease Attributes
Infections
Organisms
Indicated drugs: Asunaprevir
Elbasvir
Glecaprevir
Grazoprevir
Ledipasvir
Pibrentasvir
Simeprevir
Sofosbuvir
Velpatasvir

Resolves to

Vocabularies

MeSHM0029252ICD-10B18.2SNOMED CT128302006MedDRA10008912UMLSC0524910

What you can answer from here — as of October 25, 2026

9Indicated drugsWith each drug's targets and mechanism

Listed above

22Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

2Clinical trialsPhase, status and sponsor resolved per trial

2Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Genotype 4 Chronic Hepatitis C share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.